Holen Sie sich die Stockscreener-App
35.51
0.08%
0.03
Handel nachbörslich:
35.51
Schlusskurs vom Vortag:
$35.48
Offen:
$35.3
24-Stunden-Volumen:
480.77K
Relative Volume:
0.63
Marktkapitalisierung:
$1.54B
Einnahmen:
$384.10M
Nettoeinkommen (Verlust:
$-9.07M
KGV:
-253.64
EPS:
-0.14
Netto-Cashflow:
$11.10M
1W Leistung:
+6.00%
1M Leistung:
+7.77%
6M Leistung:
+66.48%
1J Leistung:
+37.96%
1-Tages-Spanne:
$35.06
$35.59
1-Wochen-Bereich:
$33.25
$35.59
52-Wochen-Spanne:
$17.82
$35.59
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Company Profile
Firmenname
Kiniksa Pharmaceuticals International Plc
Sektor
Telefon
(781) 431-9100
Adresse
23 OLD BOND STREET, FLOOR 3, LONDON
Vergleichen Sie KNSA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KNSA
Kiniksa Pharmaceuticals International Plc
|
35.51 | 2.54B | 384.10M | -9.07M | 11.10M | -0.14 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-13 | Eingeleitet | Citigroup | Buy |
| 2024-09-13 | Eingeleitet | Jefferies | Buy |
| 2024-05-03 | Eingeleitet | Wells Fargo | Overweight |
| 2020-06-29 | Bestätigt | BofA Securities | Buy |
| 2020-04-01 | Eingeleitet | BofA/Merrill | Buy |
| 2019-03-11 | Eingeleitet | Barclays | Overweight |
| 2018-12-12 | Bestätigt | Wedbush | Outperform |
| 2018-06-19 | Eingeleitet | JMP Securities | Mkt Outperform |
Alle ansehen
Kiniksa Pharmaceuticals International Plc Aktie (KNSA) Neueste Nachrichten
Kiniksa Pharma COO Tessari sells $535k in shares - Investing.com
Kodai Capital Management LP Buys New Stake in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
Charles Schwab Investment Management Inc. Boosts Stake in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Recent Price Trend in Kiniksa Pharmaceuticals International, plc (KNSA) is Your Friend, Here - sharewise.com
Braidwell LP Sells 1,489,538 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals Highlights Cardiovascular Focus and Growth - TipRanks
Kiniksa Q4 rev. down 40% YoY, FY22 rev. down 49% YoY. - AInvest
Trexquant Investment LP Has $5.25 Million Stake in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Court Ruling & Tariff Uncertainty: Time to Bet on POST, TME & KNSA? - Yahoo Finance
Is This a Bottoming Phase for Kiniksa Pharmaceuticals Ltd. getLinesFromResByArray error: size == 0 - thegnnews.com
Applying sector rotation models to Kiniksa Pharmaceuticals Ltd.Weekly Trend Recap & Community Verified Swing Trade Signals - Newser
Wellington Management Group LLP Acquires 21,219 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Walleye Capital LLC Purchases Shares of 86,203 Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Russell Investments Group Ltd. Acquires 83,126 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals Ltd.’s volatility index tracking explained2025 Investor Takeaways & Smart Money Movement Tracker - Newser
Charles Schwab Investment Management Inc. Purchases 42,353 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - Defense World
Vanguard Group Inc. Grows Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Will Kiniksa Pharmaceuticals Ltd. stock go up soonQuarterly Profit Summary & High Accuracy Trade Signal Alerts - Newser
Analyzing drawdowns of Kiniksa Pharmaceuticals Ltd. with statistical toolsJuly 2025 Weekly Recap & Capital Efficiency Focused Ideas - Newser
Visual analytics tools that track Kiniksa Pharmaceuticals Ltd. performanceJuly 2025 Fed Impact & Low Drawdown Investment Ideas - Newser
Statistical indicators supporting Kiniksa Pharmaceuticals Ltd.’s strength2025 Breakouts & Breakdowns & Fast Gain Swing Trade Alerts - Newser
How to forecast Kiniksa Pharmaceuticals Ltd. trends using time seriesJuly 2025 PreEarnings & AI Enhanced Trading Alerts - Newser
Biotech Investor Focus: Kiniksa Pharmaceuticals Lines Up Key September Conference Appearances at Major Banks - Stock Titan
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences - GlobeNewswire
Is Kiniksa Pharmaceuticals Ltd. a candidate for recovery playMarket Volume Report & High Win Rate Trade Tips - Newser
Russell Investments Group Ltd. Has $1.88 Million Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - Defense World
Fox Run Management L.L.C. Invests $252,000 in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Nuveen LLC Acquires Shares of 765,054 Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Vanguard Group Inc. Has $74.61 Million Stake in Kiniksa Pharmaceuticals International, plc $KNSA - Defense World
Algert Global LLC Acquires 94,653 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 52-Week HighStill a Buy? - MarketBeat
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
1,473 Shares in Kiniksa Pharmaceuticals International, plc $KNSA Acquired by US Bancorp DE - Defense World
Wall Street Analysts Believe Kiniksa Pharmaceuticals International, plc (KNSA) Could Rally 26.69%: Here's is How to Trade - MSN
Deutsche Bank AG Has $8.76 Million Stake in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Director Sells $1,600,786.80 in Stock - MarketBeat
Thomas Malley Sells 78,233 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock - MarketBeat
Thomas Malley Sells 50,129 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Stock - MarketBeat
Analysts Predict $37 for First Trust Active Factor Small Cap ETF - AInvest
Is Kiniksa Pharmaceuticals Ltd. stock entering bullish territoryWeekly Market Outlook & Free Real-Time Volume Trigger Notifications - Newser
Finanzdaten der Kiniksa Pharmaceuticals International Plc-Aktie (KNSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Kiniksa Pharmaceuticals International Plc-Aktie (KNSA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Tessari Eben | CHIEF OPERATING OFFICER |
Sep 03 '25 |
Sale |
35.50 |
15,091 |
535,730 |
44,452 |
3.60%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):